+ Regulatory
Jamie Barrand | Oct 29, 2015

Medicare patients following medication management programs more likely to stick to prescription schedules, study finds

Prime Therapeutics, LLC said Monday its recent study showed that 40 percent more of its Medicare members took medications as prescribed when they were participating in a Comprehensive Medication Review through its medication therapy management (MTM) program.

Medicare Part D prescription drug plan sponsors are mandated to have MTM programs in place.

“People not taking their medicine as directed is a major cause of hospitalization, poor health care outcomes and increased overall health care costs,” Prime Therapeutics Principal Health Outcomes Researcher Cathy Starner said. “Finding that Prime’s MTM program yields positive results for our members provides evidence our approach works. We encourage our health plans’ members to participate in MTM and it helps the plans achieve the best star rating possible. It is a win-win scenario.”

For the study, researchers  analyzed the medication-taking habits of 106,915 Prime Therapeutics' Medicare members.

The study's findings were presented at the Academy of Managed Care Pharmacy Nexus event that wrapped up Thursday in Orlando, Florida. 

For more information on the study, visit www.primetherapeutics.com.

Prime Therapeutics is an independent pharmacy benefit manager.

Organizations in this story

More News